Skip to content

Omeros OMER Common Stock

Common Stock at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$6K0.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
390M+30.0%
Immunome logo
ImmunomeIMNM
$11K+22.2%
Vor Biopharma logo
Vor BiopharmaVOR
$19K+46.2%
Annexon logo
AnnexonANNX
$162K+48.6%
Arcus Biosciences logo
Arcus BiosciencesRCUS
400M0.0%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's common stock?
Omeros (OMER) reported common stock of $720K in Q1 2026.
How has Omeros's common stock changed year-over-year?
Omeros's common stock increased by 24.1% year-over-year, from $580K to $720K.
What is the long-term trend for Omeros's common stock?
Over 5 years (2020 to 2025), Omeros's common stock has grown at a 3.1% compound annual growth rate (CAGR), from $616K to $716K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).